Determinants of the number of mammography units in 31 countries with significant mammography screening.
In the 2000s, most of the female population of industrialised countries had access to mammography breast cancer screening, but with variable modalities among the countries. We assessed the number of mammography units (MUs) in 31 European, North American and Asian countries where significant mammography activity has existed for over 10 years, collecting data on the number of such units and of radiologists by contacting institutions in each country likely to provide the relevant information. Around 2004, there were 32,324 MU in 31 countries, the number per million women ranging from less than 25 in Turkey, Denmark, the Netherlands, the United Kingdom, Norway, Poland and Hungary to more than 80 in Cyprus, Italy, France, the United States and Austria. In a multivariate analysis, the number of MUs was positively associated with the number of radiologists (P=0.0081), the number of women (P=0.0023) and somewhat with the country surface area (P=0.077). There is considerable variation in the density of MU across countries and the number of MUs in service are often well above what would be necessary according to local screening recommendations. High number of MUs in some countries may have undesirable consequences, such as unnecessarily high screening frequency and decreased age at which screening is started.
Autier
P
P
Epidemiology Methods and Support Group, International Agency for Research on Cancer, Lyon, France. autierp@iarc.fr
Ait Ouakrim
D
D
Ouakrim
D A
DA
D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D019049:Developed Countries; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D008327:Mammography / Q000706:statistics & numerical data*
J Am Coll Radiol. 2005 Jul;2(7):585-94
17411883
Eur J Cancer Prev. 2003 Jun;12(3):213-22
12771560
Eur J Public Health. 2005 Feb;15(1):70-7
15788807
Ann Oncol. 2008 Apr;19(4):614-22
18024988
J Natl Cancer Inst. 2005 Mar 2;97(5):358-67
15741572
Prev Med. 1998 Sep-Oct;27(5 Pt 1):697-701
9808801
Eur J Epidemiol. 2007;22(7):447-55
17594526
JAMA. 2003 Oct 22;290(16):2129-37
14570948
Diagn Interv Radiol. 2007 Sep;13(3):129-33
17846986
J Med Screen. 2004;11(4):187-93
15624239
Cancer. 2004 Oct 15;101(8):1850-9
15386333
Int J Cancer. 2005 Jan 20;113(3):464-70
15455383
Bull Cancer. 2002 Nov;89(11):957-62
12495883
Ann Oncol. 2008 Jun;19(6):1187-94
18325921
Ann Oncol. 2008 May;19(5):1009-18
18296422
Lancet. 2003 Apr 26;361(9367):1411-7
12727393
CMAJ. 2005 Jan 18;172(2):195-9
15655240
Lancet. 2006 Dec 9;368(9552):2053-60
17161727
Tidsskr Nor Laegeforen. 2007 May 31;127(11):1492
17551550
Ann Intern Med. 1990 Oct 1;113(7):547-52
2393209